XML 62 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Prior Financial Information - Schedule of Effect of Error Correction (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
CONSOLIDATED BALANCE SHEETS                        
Receivables, net $ 49,631 $ 14,393 $ 19,686 $ 1,007         $ 49,631      
Income taxes receivable (restated) 0       $ 5,678   $ 1,426   0 $ 5,678    
Total current assets 428,125 445,785 468,085 445,423 404,460   471,976   428,125 404,460    
Goodwill 269,053 250,860 246,688 245,757 246,416 $ 236,730 232,431 $ 232,431 269,053 246,416 $ 232,430  
Income taxes receivable, non-current 15,943 15,943 15,943 15,943 15,943 6,483 6,483 6,483 15,943 15,943    
Total non-current assets 538,088 509,111 499,347 477,236 462,901 443,942 423,741 472,866 538,088 462,901    
Total assets 966,213 [1] 954,896 967,432 922,659 867,361 [1] 871,154 895,717 843,141 966,213 [1] 867,361 [1]    
Medical liabilities 81,255       55,783       81,255 55,783 50,330  
Income taxes payable 4,279     0 0 2,438 0 8,265 4,279 0    
Current liabilities 148,610     155,542 114,719 115,173 125,873 122,553 148,610 114,719    
Deferred tax liability 14,217 24,985 30,920 30,888 30,135 27,833 31,695 17,383 14,217 30,135    
Total non-current liabilities 259,056 254,173 261,647 241,425 242,000 230,955 230,357 259,744 259,056 242,000    
Total liabilities 407,666 [1] 410,364 446,885 396,967 356,719 [1] 346,128 356,230 382,297 407,666 [1] 356,719 [1]    
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (“APC”) 14,237 40,158 41,035 53,054 56,535 89,789 140,114 113,796 14,237 56,535 113,566  
Retained earnings 182,417 186,146 162,959 151,010 137,246 124,775 90,371 80,283 182,417 137,246    
Non-controlling interest 1,749       5,940       1,749 5,940    
Stockholders’ Equity 544,310       454,107       544,310 454,107 329,463 $ 192,335
CONSOLIDATED STATEMENTS OF INCOME                        
Provision for income taxes 11,338 17,366 5,352 6,818 (4,278) (276) 28,181 8,067 40,875 31,693 56,344  
Net (loss) income (883) 23,897 11,277 11,450 (18,152) (5,229) 56,269 13,167 45,741 46,055 122,083  
Net income attributable to noncontrolling interests 2,845 712 (673) (2,314) (30,431) (39,633) 46,181 1,015 570 (22,868) 84,395  
Net income attributable to ApolloMed $ (3,728) $ 23,185 $ 11,950 $ 13,764 $ 12,279 $ 34,404 $ 10,088 $ 12,152 $ 45,171 $ 68,923 $ 37,688  
Earnings per share - basic attributable to common stock (in dollars per share) $ (0.08) $ 0.52 $ 0.27 $ 0.31 $ 0.28 $ 0.77 $ 0.23 $ 0.29 $ 1.00 $ 1.57 $ 1.03  
Earnings per share - diluted attributable to common stock (in dollars per share) $ (0.08) $ 0.50 $ 0.26 $ 0.30 $ 0.27 $ 0.74 $ 0.22 $ 0.28 $ 0.99 $ 1.52 $ 1.01  
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net income (restated)                 $ 48,936 $ 71,690 $ 38,521  
CONSOLIDATED STATEMENTS OF CASH FLOWS                        
Deferred tax                 (14,278) 7,671 396  
Receivable, net                 (38,194) (1,518) 4,134  
Medical liabilities                 22,786 5,279 (8,691)  
Income taxes payable/receivable                 6,917 (14,005) (7,083)  
Retained Earnings (Accumulated Deficit)                        
CONSOLIDATED BALANCE SHEETS                        
Retained earnings $ 182,417       $ 137,246       182,417 137,246 68,323  
Stockholders’ Equity 182,417       137,246       182,417 137,246 68,323 31,905
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net income (restated)                 45,171 68,923 37,688  
Non-controlling Interest                        
CONSOLIDATED BALANCE SHEETS                        
Non-controlling interest 1,749               1,749      
Stockholders’ Equity 1,749       5,940       1,749 5,940 87 786
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net income (restated)                 3,765 2,767 833  
Mezzanine                        
CONSOLIDATED BALANCE SHEETS                        
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (“APC”) 14,237       56,535       14,237 56,535 113,566 $ 168,724
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net (loss) income (restated)                 (3,195) (25,635) 83,562  
Mezzanine | Non-controlling Interest                        
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net (loss) income (restated)                 (3,195)      
As Previously Reported                        
CONSOLIDATED BALANCE SHEETS                        
Receivables, net 52,629 $ 12,224 $ 12,639 $ 0         52,629      
Income taxes receivable (restated) 4,015       0   $ 0   4,015 0    
Total current assets 435,138 443,616 461,038 444,416 398,782   470,550   435,138 398,782    
Goodwill 275,675 257,482 253,310 252,379 253,039 $ 243,353 239,053 $ 239,053 275,675 253,039    
Income taxes receivable, non-current 0 0 0 0 0 0 0 0 0 0    
Total non-current assets 528,767 499,790 490,026 467,915 453,581 444,082 423,880 473,005 528,767 453,581    
Total assets 963,905 943,406 951,064 912,331 852,363 871,294 894,430 843,280 963,905 852,363    
Medical liabilities 84,253               84,253      
Income taxes payable 0     4,894 652 4,024 2,215 12,059 0 652    
Current liabilities 147,329     160,436 115,371 116,759 128,088 126,347 147,329 115,371    
Deferred tax liability 3,042 4,701 9,257 9,686 9,127 19,592 21,242 10,038 3,042 9,127    
Total non-current liabilities 247,881 233,889 239,984 220,223 220,992 222,714 219,904 252,399 247,881 220,992    
Total liabilities 395,210 390,080 425,222 380,659 336,363 339,473 347,992 378,746 395,210 336,363    
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (“APC”) 13,682 39,820 39,997 52,151 55,510 91,500 141,856 114,847 13,682 55,510 114,237  
Retained earnings 192,678 195,278 169,292 157,893 143,629 129,859 95,580 82,922 192,678 143,629    
Non-controlling interest 2,191               2,191      
Stockholders’ Equity 555,013       460,490       555,013 460,490 330,911  
CONSOLIDATED STATEMENTS OF INCOME                        
Provision for income taxes 9,984 13,867 6,038 6,195 (3,121) (120) 24,920 6,776 36,085 28,454 56,107  
Net (loss) income 471 27,396 10,591 12,073 (19,309) (5,385) 59,530 14,458 50,531 49,294 122,320  
Net income attributable to noncontrolling interests 3,071 1,410 (808) (2,191) (33,079) (39,664) 46,872 1,307 1,482 (24,564) 84,454  
Net income attributable to ApolloMed $ (2,600) $ 25,986 $ 11,399 $ 14,264 $ 13,770 $ 34,279 $ 12,658 $ 13,151 $ 49,049 $ 73,858 $ 37,866  
Earnings per share - basic attributable to common stock (in dollars per share) $ (0.06) $ 0.58 $ 0.25 $ 0.32 $ 0.31 $ 0.77 $ 0.29 $ 0.31 $ 1.09 $ 1.69 $ 1.04  
Earnings per share - diluted attributable to common stock (in dollars per share) $ (0.06) $ 0.56 $ 0.25 $ 0.31 $ 0.30 $ 0.74 $ 0.28 $ 0.30 $ 1.08 $ 1.63 $ 1.01  
CONSOLIDATED STATEMENTS OF CASH FLOWS                        
Deferred tax                 $ (7,681) $ (5,952) $ (6,620)  
Receivable, net                 (41,192)      
Medical liabilities                 25,784      
Income taxes payable/receivable                 (4,470) (3,621) (304)  
As Previously Reported | Retained Earnings (Accumulated Deficit)                        
CONSOLIDATED BALANCE SHEETS                        
Retained earnings $ 192,678       $ 143,629       192,678 143,629 69,771  
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net income (restated)                 49,049 73,858 37,866  
As Previously Reported | Non-controlling Interest                        
CONSOLIDATED BALANCE SHEETS                        
Non-controlling interest 2,191               2,191      
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net income (restated)                 4,207      
As Previously Reported | Mezzanine                        
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net (loss) income (restated)                 (2,725) (27,331) 83,621  
Adjustments                        
CONSOLIDATED BALANCE SHEETS                        
Receivables, net (2,998) $ 2,169 $ 7,047 $ 1,007         (2,998)      
Income taxes receivable (restated) (4,015)       5,678   $ 1,426   (4,015) 5,678    
Total current assets (7,013) 2,169 7,047 1,007 5,678   1,426   (7,013) 5,678    
Goodwill (6,622) (6,622) (6,622) (6,622) (6,623) $ (6,623) (6,622) $ (6,622) (6,622) (6,623)    
Income taxes receivable, non-current 15,943 15,943 15,943 15,943 15,943 6,483 6,483 6,483 15,943 15,943    
Total non-current assets 9,321 9,321 9,321 9,321 9,320 (140) (139) (139) 9,321 9,320    
Total assets 2,308 11,490 16,368 10,328 14,998 (140) 1,287 (139) 2,308 14,998    
Medical liabilities (2,998)               (2,998)      
Income taxes payable 4,279     (4,894) (652) (1,586) (2,215) (3,794) 4,279 (652)    
Current liabilities 1,281     (4,894) (652) (1,586) (2,215) (3,794) 1,281 (652)    
Deferred tax liability 11,175 20,284 21,663 21,202 21,008 8,241 10,453 7,345 11,175 21,008    
Total non-current liabilities 11,175 20,284 21,663 21,202 21,008 8,241 10,453 7,345 11,175 21,008    
Total liabilities 12,456 20,284 21,663 16,308 20,356 6,655 8,238 3,551 12,456 20,356    
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (“APC”) 555 338 1,038 903 1,025 (1,711) (1,742) (1,051) 555 1,025 (671)  
Retained earnings (10,261) (9,132) (6,333) (6,883) (6,383) (5,084) (5,209) (2,639) (10,261) (6,383)    
Non-controlling interest (442)               (442)      
Stockholders’ Equity (10,703)       (6,383)       (10,703) (6,383) (1,448)  
CONSOLIDATED STATEMENTS OF INCOME                        
Provision for income taxes 1,354 3,499 (686) 623 (1,157) (156) 3,261 1,291 4,790 3,239 237  
Net (loss) income (1,354) (3,499) 686 (623) 1,157 156 (3,261) (1,291) (4,790) (3,239) (237)  
Net income attributable to noncontrolling interests (226) (698) 135 (123) 2,648 31 (691) (292) (912) 1,696 (59)  
Net income attributable to ApolloMed $ (1,128) $ (2,801) $ 551 $ (500) $ (1,491) $ 125 $ (2,570) $ (999) $ (3,878) $ (4,935) $ (178)  
Earnings per share - basic attributable to common stock (in dollars per share) $ (0.02) $ (0.06) $ 0.02 $ (0.01) $ (0.03) $ 0 $ (0.06) $ (0.02) $ (0.09) $ (0.12) $ (0.01)  
Earnings per share - diluted attributable to common stock (in dollars per share) $ (0.02) $ (0.06) $ 0.01 $ (0.01) $ (0.03) $ 0 $ (0.06) $ (0.02) $ (0.09) $ (0.11) $ 0  
CONSOLIDATED STATEMENTS OF CASH FLOWS                        
Deferred tax                 $ (6,597) $ 13,623 $ 7,016  
Receivable, net                 2,998      
Medical liabilities                 (2,998)      
Income taxes payable/receivable                 11,387 (10,384) (6,779)  
Adjustments | Retained Earnings (Accumulated Deficit)                        
CONSOLIDATED BALANCE SHEETS                        
Retained earnings $ (10,261)       $ (6,383)       (10,261) (6,383) (1,448)  
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net income (restated)                 (3,878) (4,935) (178)  
Adjustments | Non-controlling Interest                        
CONSOLIDATED BALANCE SHEETS                        
Non-controlling interest $ (442)               (442)      
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net income (restated)                 (442)      
Adjustments | Mezzanine                        
CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS’ EQUITY                        
Net (loss) income (restated)                 $ (470) $ 1,696 $ (59)  
[1] The Company’s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company’s consolidated VIEs totaling $523.7 million and $580.9 million as of December 31, 2022 and December 31, 2021, respectively, and total liabilities of the Company’s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $131.8 million and $94.8 million as of December 31, 2022 and December 31, 2021, respectively. These VIE balances do not include $304.8 million of investment in affiliates and $30.3 million of amounts due from affiliates as of December 31, 2022 and $802.8 million of investment in affiliates and $6.6 million of amounts due from affiliates as of December 31, 2021 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 19 – “Variable Interest Entities (VIEs)” for further detail.